Loss of the p16(INK4a) and p15(INK4b) genes, as well as neighboring 9p21 markers, in sporadic melanoma

Cancer Research

Volumn 56, Issue 21, 1996, Pages 5023-5032

  Flores, José F ^a   Walker, Graeme J ^a,b   Glendening, J Michael ^a   Haluska, Frank G ^c   Castresana, Javier S ^d   Rubio, Mari Paz ^d   Pastorfide, Georgina C ^c   Boyer, Laurie A ^e   Kao, Wynn H ^e   Bulyk, Martha L ^e   Barnhill, Raymond L ^f   Hayward, Nicholas K ^b   Housman, David E ^e   Fountain, Jane W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FREQUENCY ANALYSIS; GENE DELETION; GENE FREQUENCY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; CELL CULTURE; CHROMOSOME 9; CHROMOSOME DELETION; GENETIC MARKER; GENETICS; METASTASIS; MUTATION;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; MELANOMA; MUTATION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0029658666     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Fountain, J. W., Bale, S J, Housman, D. E., and Dracopoli, N. C. Genetics of melanoma. Cancer Surv, 9: 645-671, 1990.
2. Cowan, J M., Halaban, R., and Francke, U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas J. Natl. Cancer Inst., 80: 1159-1164, 1988.
3. Parmiter, A. H, Balaban, G., Clark, W H, Jr, and Nowell, P C. Possible involvement of the chromosome region 10q24-26 in early stages of melanocytic neoplasia. Cancer Genet. Cytogenet., 30: 313-317, 1988.
4. Dracopoli, N. C., Alhadeff, B, Houghton, A. N., and Old, L J Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma Cancer Res, 47: 3995-4000, 1987
5. Pedersen, M. I., and Wang, N. Chromosomal evolution in the progression and metastasis of human malignant melanoma Cancer Genet Cytogenet., 41: 185-201, 1989.
6. Fountain, J. W., Karayiorgou, M, Emstoff, M. S, Kirkwood, J. M., Vlock, D R, Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S, Houghton, A N., Lahti, J., Kidd, V, Housman, D E., and Dracopoli, N. C. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA, 89: 10557-10661, 1992
7. Cannon-Albright, L A., Goldgar, D. E, Meyer, L J., Lewis, C. M, Anderson, D E., Fountain, J W., Hegi, M E., Wiseman, R. W., Petty, E. M., Bale, A E, Olopade, O I Diaz, M O., Kwiatkowski, D. J, Piepkorn, M. W., Zone, J. J, and Skolnick, M H Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science (Washington DC), 258: 1148-1152, 1992.
8. Kamb, A, Gruis, N A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V, Stockert, E, Day, R. S, III, Johnson, B. E, and Skolnick, M H. A cell cycle regulator potentially invoked in the genesis of many tumor types Science (Washington DC), 264: 436-440, 1994.
9. Nobori, T., Muira, K., Wu, D., Lois, A, Takabayashi, K., and Carson, D A Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature (Lond.), 368: 753-756, 1994.
10. Kamb, A, Shattuck-Eidens, D, Eeles, R, Liu, Q., Gruis, N. A., Ding, W, Hussey, C., Tran, T, Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J F., Anderson, D. E., Bergman, W, Frants, R., Goldgar, D. E, Green, A, MacLennan, R., Martin, N. G., Meyer, L J., Youl, P., Zone, J. J, Skolnick, M. H., and Cannon-Albright, L. A Analysis of the p16 gene (CDKN2) as a candidate for the 9p melanoma susceptibility locus. Nat. Genet., 8: 22-26, 1994.
11. Hussussian, C. J. Struewing, J P, Goldstein, A. M, Higgins, P. A. T, Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M A., and Dracopoli, N C Germline p16 mutations in familial melanoma. Nat Genet., 8: 15-21, 1994.
12. Gruis, N A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., and Frants, R. R Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat. Genet., 10, 351-353, 1995.
13. INK4 gene in Australian melanoma kindreds. Hum. Mol. Genet., 4: 1845-1852, 1995.
14. Serrano, M, Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
15. Greene, M H., and Fraumeni, J F, Jr. The hereditary variant of malignant melanoma. In: W H. Clark, Jr., L. I Goldman, and M J. Mastrangelo (eds.), Human Malignant Melanoma, pp 139-166. New York: Grune and Stratton, 1979.
16. Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M., Singh, A D, Shields, J A., Shields, C. L., Croce, C. M., and Huebner, K. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK41, in melanoma. Cancer Res., 54, 5269-5272, 1994.
17. Gruis, N. A., Weaver-Feldhaus, J, Liu, Q., Frye, C., Eeles, R, Orlow, I., Lacombe, L, Ponce-Castenada, V., Lianes, P, Latres, E., Skolnick, M., Cordon-Cardo, C, and Kamb, A. Genetic evidence in melanoma and bladder cancer that p16 and p53 function in separate pathways of tumor suppression. Am J. Pathol., 146: 1199-1206, 1995
18. Holland, E. A., Beaton, S C, Edwards, B. G., Kefford, R. F., and Mann, G. J Loss of heterozygosity and homozygous deletion on 9p21-22 in melanoma. Oncogene, 9: 1361-1365, 1994.
19. Puig, S., Ruiz, A., Lazaro, C., Castel, T, Lynch, M., Palou, J, Vilalta, A., Weissenbach, J., Mascaro, J-M., and Estivill, X. Chromosome 9p deletions in cutaneous malignant melanoma tumors, the minimal deleted region involves markers outside of the p16 (CDKN2) gene. Am. J Hum. Genet., 57: 395-402, 1995.
20. Walker, G. J., Palmer, J. M., Walters, M K., Nancarrow, D J., Parsons, P. G., and Hayward, N. K. Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions Oncogene, 9: 819-824, 1994.
21. Weaver-Feldhaus, J, Gruis, N. A., Neuhausen, S., Le Paslier, D., Stockert, E, Skolnick, M. H., and Kamb, A. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc Natl Acad. Sci USA, 91: 7563-7567, 1994.
22. Liu, Q., Neuhausen, S, McClure, M., Frye, C., Weaver-Feldhaus, J., Gruis, N. A., Eddington, K., Allalunis-Tumer, M. J., Skolnick, M. H., Fujimura, F. K., and Kamb, A. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene, 10: 1061-1067, 1995.
23. Pollock, P. M., Yu, F, Qiu, L, Parsons, P. G, and Hayward, N K. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene, 11: 663-668, 1995.
24. Reed, J. A., Loganzo, F., Jr., Shea, C. R, Walker, G. J., Flores, J. F., Glendening, J. M., Bogdany, J. K., Shiel, M. J, Haluska, F. G, Fountain, J. W., and Albino, A. P. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression Cancer Res., 55: 2713-2718, 1995.
25. Jen, J., Harper, W, Bigner, S H., Bigner, D D., Papadopoulos, N, Markowitz, S, Willson, J. K. V, Kinzler, K. W., and Vogelstein, B. Deletion of p15 and p16 in brain tumors. Cancer Res., 54: 6353-6358, 1994.
26. Cairns, P., Polasci, T J., Eby, Y, Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J L., Buckler, A., Gabrielson, E., Tockman, M, Cho, K. R., Hedrick, L., Bova, G. S., Isaaca, W., Koch, W., Schwab, D. and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat. Genet, 11: 210-212, 1995.
27. Xiao, S, Li, D., Vijg, J, Sugarbaker, D. J., Corson, J. M, and Fletcher, J. A. Codeletion of p15 and p16 genes in primary malignant mesothelioma Oncogene, 11: 511-515, 1995.
28. Xiao, S., Li, D., Corson, J. M., Vijg, J., and Fletcher, J. A. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res., 55: 2968-2971, 1995.
29. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S., and Nakamura, Y. Frequent somatic mutation of the MTSI/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54: 3396-3397, 1994.
30. Caldas, C., Hahn, S. A., da Costa, L. T, Redston, M S., Schutte, M, Seymour, A. B., Weinstein, C. L, Hruban, R H, Yeo, C J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet, 8: 27-32, 1994.
31. Ink4B/MTS2 genes in biliary tract cancers Cancer Res., 55: 2756-2760, 1995.
32. Cavenee, W. K., Dryja, T. P, Phillips, R. A, Benedict, W F., Godbout, R., Gallie, B L., Murphree, A L, Strong, L. C., and White, R. L Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond), 305, 779-784, 1983.
33. INK4B is a potential effector of TGF-β-induced cell cycle arrest Nature (Lond), 371: 257-261, 1994
34. INK4 gene) during tumor progression in a sporadic melanoma patient. Cancer Res., 55: 5531-5535, 1995.
35. Stone, S., Jiang, P., Dayananth, P, Tavtigian, S. V., Katcher, H., Parry, D., Peters, G., and Kamb, A Complex structure and regulation of the P16 (MTS1) locus. Cancer Res., 55: 2988-2994, 1995.
36. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res, 55: 1448-1451, 1995.
37. INK4B. Cancer Res 56: 722-727, 1996.
38. Stone, S, Dayananth, P, Jiang, P, Weaver-Feldhaus, J M., Tavtigian, S. V, Skolnick, M. K, and Kamb, A. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene Oncogene, 11: 987-991, 1995.
39. INK4A transcript. Cancer Res, 55: 2995-2997, 1995.
40. Quelle, D. E., Zindy, F., Ashmun, R A., and Sherr, C. J. Alternative reading frames of the INKa tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell, 83: 993-1000, 1995.
41. Walker, G. J., Palmer, J M., Walters, M. K., and Hayward, N K. A genetic model for melanoma tumorigenesis based on allelic deletions. Genes Chromosomes & Cancer, 12: 134-141, 1995.
42. Ausubel, F. M, Brent, R., Kingston, R. E., Moore, D. D., Seidman, J G, Smith, J. A., and Struhl, K. Preparation and analysis of DNA. In: Current Protocols in Molecular Biology, pp. 2.0.1-2.14.8. Boston, John Wiley & Sons, Inc., 1994.
43. Fountain, J. W., Karayiorgou, M., Taruscio, D, Graw, S. L., Buckler, A. J., Ward, D. C., Dracopoli, N. C., and Housman, D. E. Genetic and physical map of the interferon region on chromosome 9p Genomics, 14: 105-112, 1992.
44. Buckler, A. J, Chang, D. D., Graw, S. L., Brook, J. D., Haber, D. A., Sharp, P. A. and Housman, D. A. Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proc. Nati Acad Sci. USA, 88: 4005-4009, 1991.
45. Fountain, J. W., Graw, S L, Kao, W., Stanton, V. P., Aburatani, H., Munroe, D. J, Jackson, C L., Dracopoli, N. C., and Housman, D. E. Further characterization of the 9p21 region frequently deleted in human cutaneous melanoma. Am. J. Hum. Genet, 51 (suppl.): A51, 1992.
46. Olopade, O. I, Homkala, H. M., Hagos, F., Sveen, L. W, Espinosa, R., III, Dreyling, M H, Gursky, S, Stadler, W. M., Le Beau, M. M., and Bohlander, S. K. Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phorphorylase gene from the tumor suppressor region on 9p21 Proc. Natl. Acad. Sci. USA, 92: 6489-6493, 1995.
47. Bohlander, S. K., Dreyling, M H., Hagos, F, Sveen, L., Olopade, O. I., and Diaz, M. O. Mapping of a putative tumor suppressor gene on chromosome 9 bands p21-22 with microdissection probes. Genomics, 24: 211-217, 1994
48. Henco, K, Brosius, J., Fujisawa, A., Fujisawa, J-I, Haynes, J R., Hochstadt, J, Koviacic, T, Pasek, M, Schambock, A., Schmid, J., Todokoro, K., Walchli, M., Nagata, S., and Weissman, C. Structural relationship of human interferon α genes and pseudogenes. J. Mol Biol. 185: 227-260, 1985.
49. INK4 alterations in squamous cell carcinoma of the bladder. J. Natl. Cancer Inst., 87: 1383-1393, 1995.
50. ink4) in human breast carcinomas. Cancer Res., 54: 5262-5264, 1994.
51. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1285, 1995.
52. Wiest, J., Franklin, W., Otstot, J, and Anderson, M Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung Proc Am. Assoc Cancer Res., 37: 593, 1996
53. Thompson, F. H, Emerson, J., Olson, S, Weinstein, R., Leavitt, S. A., Leong, S. P. L., Emerson, S., Trent, J. M., Nelson, M A., Salmon, S E., and Taetle, R. Cytogenetics of 158 patients with regional or disseminated melanoma Cancer Genet Cytogenet. 83: 93-104, 1995.
54. Healy, E., Belgaid, C. E, Takata, M, Vahlquist, A., Rehman, I., Rigby, H., and Rees, J L. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi Cancer Res., 56: 589-593, 1996.
55. INK4 function Nat. Genet., 10: 114-116, 1995.
56. Koh, J., Enders, G. H., Dynlacht, B. D, and Harlow, E. Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond.), 375: 506-510, 1995.
57. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J, Strauss, M, Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16 Nature (Lond), 375: 503-506, 1995.
58. Merlo, A, Herman, J G., Mao, L., Lee, D. J, Gabrielson, E., Burger, P. C, Baylin, S. B, and Sidransky, D 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med., 1: 686-692, 1995.